Predicting the molecular subtypes of 2021 WHO grade 4 glioma by a multiparametric MRI-based machine learning model
Abstract Background Accurately distinguishing the different molecular subtypes of 2021 World Health Organization (WHO) grade 4 Central Nervous System (CNS) gliomas is highly relevant for prognostic stratification and personalized treatment. Objectives To develop and validate a machine learning (ML)...
Saved in:
| Main Authors: | Wenji Xu, Yangyang Li, Jie Zhang, Zhiyi Zhang, Pengxin Shen, Xiaochun Wang, Guoqiang Yang, Jiangfeng Du, Hui Zhang, Yan Tan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | BMC Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12885-025-14529-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular Biomarkers of Glioma
by: Punsasi Rajakaruna, et al.
Published: (2025-05-01) -
Lactylation-related gene signatures identify glioma molecular subtypes with prognostic, immunological, and therapeutic implications
by: Yanliang Tang, et al.
Published: (2025-07-01) -
Diffuse gliomas: insights into clinical and histopathological features and survival rates from two centers in a middle-income country
by: Edgar G. Ordóñez-Rubiano, et al.
Published: (2025-07-01) -
Clinical importance of eflornithine (α-difluoromethylornithine) for the treatment of malignant gliomas
by: Victor A Levin, et al.
Published: (2018-04-01) -
Immunohistochemical analysis of IDH1, ATRX, p53, and Ki-67 in glioblastoma and diffuse infiltrative glioma: Therapeutic and prognostic correlation
by: Hasbay Bermal, et al.
Published: (2025-01-01)